Marinus Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.84 | -100% |
| P/S |
|
18.11 | 33.76 | -46.36% |
|
|
| P/BV |
|
33.47 | 4.82 | 594.28% |
|
|
| P/FCF |
|
-4.22 | 60.98 | -106.92% |
|
|
| Ev/Ebitda |
|
-4.21 | -22.12 | -80.98% |
|
|
| Ev/S |
|
17.78 | 22.56 | -21.21% |
|
|
| Ev/FCF |
|
-4.66 | 68.75 | -106.78% |
|
|
| E/P |
|
-0.2837 | 0.0178 | -1696.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-422.52 | 4.83 | -8847.11% | -1219.25 | -65.35% |
| ROE |
|
-843.45 | 9.61 | -8880.34% |
|
|
| ROA |
|
-82.74 | 0.3359 | -24731.18% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-456.31 | -25.17 | 1712.9% |
|
|
| ROCE |
|
-784.28 | 15.33 | -5215.61% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5801 | -3.67 | -84.17% | -2.85 | -79.61% |
| Nеt Debt/Ebitda |
|
0.078 | -3.44 | -102.27% |
|
|
| Debt/Ratio |
|
0.4444 | 0.1972 | 125.43% |
|
|
| Debt/Equity |
|
18.09 | 1.54 | 1071.05% |
|
|
| Debt/Net Income |
|
-0.5372 | 10.31 | -105.21% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
30889 | -56.89 | -54396.01% |
| Growth impulse Ebitda 5 years |
|
141.83 | -64.81 | -318.84% |
| Growth impulse Net Income 5 years |
|
162.74 | -58.33 | -379% |
| Growth impulse FCF 5 years |
|
140.96 | -47 | -399.91% |
| Growth impulse EPS 5 years |
|
-33.38 | -32.41 | 2.99% |
IP Score
3.93/10
